Introduction {#sec1-1}
============

The incidence of ischemic cerebrovascular disease, which is one of the main diseases threatening the rapidly aging human population, has been increasing over the years. Reperfusion is beneficial in reducing ischemic brain injury and in recovering some reversible damage. However, recent studies found that blood reperfusion for ischemic tissue could induce further damage and dysfunction in some cases. Therefore consideration is always taken of how to inhibit reperfusion injury during the treatment of ischemic stroke (Prakash and Kumar, 2013).

Cerebral ischemia is caused by free radical damage (Floyd and Carney, 1992). Proanthocyanidins (PC), which are a form of condensed tannins or oligomeric flavonoids, and have been known to be extremely strong antioxidants (Aras et al., 2015). Many studies have proved that PC has strong anti-inflammatory activity, and this effect was associated with reduced activation of nuclear factor-kappa B p65 pathway (Li et al., 2001; La et al., 2010; Bak et al., 2013). Growing evidence has suggested the effect of PC on improving blood circulation, visual protection and edema elimination (Pons et al., 2014; Yang et al., 2016). Whether PC can be used to treat cerebral ischemia/reperfusion (I/R) injury remains unclear. The ginkgo leaf has an important medicinal value and the content of PC in its extracts (7%) is higher than in many other plants (Kan et al., 2013).

In this study, we investigated the protective effects of ginkgo PC (GPC) on the rat with cerebral I/R injury, and found some clues on the underlying mechanism of protection. We also included grape seed PC (GSPC) to compare the PC effects from another source, because PC can be extracted from different plant species.

Nimodipine is commonly used for the effective treatment of cerebral ischemia caused by cerebral vasospasm after subarachnoid hemorrhage. It regulates the intracellular calcium level effectively and helps maintain the normal physiological function, especially the cerebrovascular system (Honig, 1991). In our experiment, we used nimodipine as a positive control.

Materials and Methods {#sec1-2}
=====================

Ethics statement {#sec2-1}
----------------

The animal studies were approved by the Experimental Animal Ethics Committee of Zhejiang Key Laboratory of Traditional Chinese Medicine Pharmaceutical Technology of China (animal license No. 2015-0003) and performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Precautions were taken to minimize suffering and the number of animals used in each experiment.

Experimental animals {#sec2-2}
--------------------

Fifty-six adult male Sprague-Dawley rats, weighing 250--320 g and aged 8--10 weeks, were purchased from Zhejiang Experimental Animals Center in China (license No. 2008-0016). The rats were equally and randomly divided into seven groups: I/R, sham operation, nimodipine (I/R + 2 mg/kg nimodipine), GPC low-, moderate- and high-dose (GPCL, GPCM, GPCH; I/R injury + 20, 40, 80 mg/kg GPC), and GSPC (I/R injury + 40 mg/kg GSPC). Before the experiment, the rats were acclimatized in individual cages for one week at 20--25°C, with standard chow and tap water.

PC pre-treatment {#sec2-3}
----------------

At 1, 24, 48, 72 hours before operation, the rats in the nimodipine, GPCL, GPCM, GPCH, and GSPC groups were intraperitoneally injected with either 2 mg/kg nimodipine (Jiangsu Jiquan Pharmaceutical Co., Ltd., China; calculated by body surface areas), 20, 40, 80 mg/kg GPC (0.2 g/L, dissolved in normal saline, stored in cool dry place and protect from light; Zhejiang Conba Pharmaceutical Co., Ltd., China) or 40 mg/kg GSPC (dissolved in normal saline, stored in cool dry place and protect from light; Zhejiang Conba Pharmaceutical Co., Ltd.), respectively. The rats in the I/R and sham operation groups were intraperitoneally injected with normal saline (10 mL) at the same time points.

Model establishment {#sec2-4}
-------------------

Models of cerebral I/R injury were established in the rats based on the methods described by Longa et al. (1989). Briefly, rats were intraperitoneally anesthetized with 10% chloral hydrate (300 mg/kg; Shanghai Baihe Chemical Company, China). The right common carotid artery, external carotid artery, and internal carotid artery were exposed. A 4--0 suture (Ningbo Medicinal Suture Needle Co., Ltd., Ningbo, China; diameter 0.26 mm) with a blunted tip coated with poly-L-lysine was gently advanced into the internal carotid artery through the external carotid artery. The suture was advanced 18--20 mm (reaching the origin of the right middle cerebral artery) beyond the carotid artery bifurcation. The suture was slowly removed after 2 hours of middle cerebral artery occlusion and followed by reperfusion.

After the 2-hour period of ischemia, without anesthesia or cutting the skin, the nylon thread was gently removed to achieve middle cerebral artery reperfusion. If Homer\'s sign occurred in the right and left anterior limbs, the models of ischemia were considered successful. The sham operation group followed the same steps above without the insertion of a surgical line. The mortality rate in each group was recorded.

Neurobehavioral evaluation {#sec2-5}
--------------------------

Neurological function scores were calculated according to Zea Longa\'s 5-point scale (Roof et al., 2001), at 4, 8, and 24 hours after reperfusion. A higher score means a higher level of behavior disorder.

2,3,5-Triphenyltetrazolium chloride (TTC) staining {#sec2-6}
--------------------------------------------------

After neurobehavioral evaluation and 24 hours after reperfusion, the rats were decapitated. The olfactory bulb, cerebellum and lower brain stem were removed. Five slices of brain tissue were placed into 0.25% TTC (Sigma, Munich, German) solution at 37°C for 30 minutes in the dark, and then fixed with 10% formalin for 4 hours (Chen et al., 2010). We calculated and compared the infarct volume with a morphology analysis system (Jiangsu JEDA Science and Technology Development Co., Ltd., Jiangsu Province, China).

Superoxide dismutase (SOD) activity, malondialdehyde (MDA) and nitric oxide (NO) contents in brain tissue of rats with cerebral I/R injury {#sec2-7}
------------------------------------------------------------------------------------------------------------------------------------------

At 24 hours after reperfusion, the brain was stripped quickly and washed with normal saline. Brain homogenates in cold normal saline (10% w/v) were made using a glass homogenizer. They were then centrifuged and the supernatant was used for biochemical determination. SOD activity was detected by xanthine oxidation method with a SOD Detection Kit (Jiangsu Jiancheng Bioengineering Institute, China). MDA contents were measured by thiobarbituric acid colorimetric method with an MDA Detection Kit (Jiangsu Jiancheng Bioengineering Institute). NO contents were measured by nitric reductase with an NO Detection Kit (Jiangsu Jiancheng Bioengineering Institute). The contents of tissue proteins were determined with Coomassie Brilliant Blue (Bennett and Scott, 1971). The methods used followed the specific instructions of each kit.

Statistical analysis {#sec2-8}
--------------------

Data, expressed as the mean ± SD, were analyzed by SPSS 17.0 software (SPSS, Chicago, IL, USA). The comparisons among groups were made by one-way analysis of variance followed by Bonferroni *post-hoc* test. A value of *P* \< 0.05 was considered statistically significant.

Results {#sec1-3}
=======

GPC decreased mortality rate of rats with cerebral I/R injury {#sec2-9}
-------------------------------------------------------------

The mortality rate of cerebral I/R model was high 24 hours after reperfusion (**[Figure 1](#F1){ref-type="fig"}**). The most important cause of death was asphyxia induced by epilepsy after brain injury, followed by subarachnoid hemorrhage. There was no mortality in the nimodipine group. GPC significantly reduced the mortality rate of rats in a dose-dependent manner and GSPC also resulted in a decreased mortality.

![Mortality rate in rats of each group 24 hours after focal cerebral I/R injury.\
I/R group: Focal cerebral ischemia model only; nimodipine group: I/R injury + nimodipine; GPCL, GPCM, GPCH groups: I/R injury + 20, 40, 80 mg/kg GPC, respectively; GSPC group: I/R injury + 40 mg/kg GSPC. I/R: Ischemia/reperfusion; Nim: nimodipine; GPC: ginkgo proanthocyanidins; GPCL: low-dose GPC; GPCM: moderate-dose GPC; GPCH: high-dose GPC; GSPC: grape seed proanthocyanidins.](NRR-11-1779-g002){#F1}

GPC improved neurological function of rats with cerebral I/R injury {#sec2-10}
-------------------------------------------------------------------

Rats in each group had obvious symptoms of neurological impairment, including convulsion, contralateral dumping, and rotary motion 4 hours after reperfusion. Rats in all groups had similar severity. Neural injury was mitigated 8 and 24 hours after reperfusion, especially in the nimodipine, GPCM and GPCH groups (**[Table 1](#T1){ref-type="table"}**).

###### 

Effect of GPC on neurological function impairment in rats with focal cerebral I/R injury

![](NRR-11-1779-g003)

Effect of GPC on cerebral infarct volume in rats with focal cerebral ischemia {#sec2-11}
-----------------------------------------------------------------------------

Cerebral infarct volume is the intuitive and accurate indicator to evaluate cerebral ischemia (Zhang et al., 2014b). The results suggested that no significant difference in the infarct volume was determined between the GPCL or the GSPC group and the I/R group (*P* \> 0.05). The infarct volumes were significantly smaller in the GPCM and GPCH group compared with the I/R group (*P* \< 0.01). The infarct volume was similar between the GPCH and nimodipine groups (*P* \> 0.05; **[Figure 2](#F2){ref-type="fig"}**).

![Effect of GPC on infarct volume in rats 24 hours after cerebral I/R injury by TTC staining.\
(A--G) Coronal sections of rat brains in the sham operation, I/R, nimodipine, GPCL, GPCM, GPCH, and GSPC groups. Red is normal tissue and white is ischemic tissue. (H) Infarct volume 24 hours after reperfusion. Infarct volume percentage (%) = white tissue volume/total volume × 100%. Sham operation group: Without modeling; I/R group: focal cerebral ischemia model only; nimodipine group: I/R injury + nimodipine; GPCL, GPCM, GPCH groups: I/R injury + 20, 40, 80 mg/kg GPC, respectively; GSPC group: I/R injury + 40 mg/kg GSPC. Data are expressed as the mean ± SD, with eight rats in each group. \#\#*P* \< 0.01, *vs*. I/R group (one-way analysis of variance followed by Bonferroni *post-hoc* test). I/R: Ischemia/reperfusion; Nim: nimodipine; TTC: 2,3,5-triphenyltetrazolium chloride; GPC: ginkgo proanthocyanidins; GPCL: low-dose GPC; GPCM: moderate-dose GPC; GPCH: high-dose GPC; GSPC: grape seed proanthocyanidins.](NRR-11-1779-g004){#F2}

GPC improved SOD activity, MDA and NO contents in the brain of rats with cerebral I/R injury {#sec2-12}
--------------------------------------------------------------------------------------------

SOD activity of the rats was significantly lower in the I/R group than in the sham operation group (*P* \< 0.01). SOD activity was significantly higher in the GPCL, GPCM and GPCH groups than in the I/R group (*P* \< 0.05 or *P* \< 0.01). No significant difference in SOD activity was detected between the nimodipine or GSPC groups and the I/R group (*P* \> 0.05; **[Figure 3A](#F3){ref-type="fig"}**).

![Effect of GPC on SOD activity, MDA and NO contents in the brain of rats 24 hours after cerebral I/R injury.\
(A) SOD activity (U/mg); (B) MDA (nmol/mg); (C) NO content (μmol/g). Sham operation group: Without modeling; I/R group: focal cerebral ischemia model only; nimodipine group: I/R injury + nimodipine; GPCL, GPCM, GPCH groups: I/R injury + 20, 40, 80 mg/kg GPC, respectively; GSPC group: I/R injury + 40 mg/kg GSPC. Data are expressed as the mean ± SD, with eight rats in each group. \*\**P* \< 0.01, *vs*. sham operation group; \#*P* \< 0.05, \#\#*P* \< 0.01, *vs*. I/R group (one-way analysis of variance followed by Bonferroni *post-hoc* test). I/R: Ischemia/reperfusion; Nim: nimodipine; GPC: ginkgo proanthocyanidins; GPCL: low-dose GPC; GPCM: moderate-dose GPC; GPCH: high-dose GPC; GSPC: grape seed proanthocyanidins; SOD: superoxide dismutase; MDA: malondialdehyde; NO: nitric oxide.](NRR-11-1779-g005){#F3}

The MDA content was significantly higher in the I/R group than in the sham operation group (*P* \< 0.01). MDA contents were significantly lower in the GPCM and GPCH groups than in the I/R group (*P* \< 0.01). The nimodipine and GSPC groups had lower mean MDA content than the I/R group, but were not significantly different (*P* \> 0.05; **[Figure 2B](#F2){ref-type="fig"}**).

NO content was significantly higher in the I/R group than in the sham operation group (*P* \< 0.01). NO content decreased significantly in the GPCL, GPCM, GPCH and nimodipine groups compared with the I/R group (*P* \< 0.01). No significant difference in NO content was detectable between the GSPC and I/R groups (*P* \> 0.05; **[Figure 2C](#F2){ref-type="fig"}**).

Discussion {#sec1-4}
==========

Middle cerebral artery is where stroke always happens and the infarction in the middle cerebral artery area accounts for 82.2% in patients with cerebral infarction. The occlusion model of focal cerebral ischemia in the middle cerebral artery is considered to be an ideal model (Morin and Simon, 2006; Wu et al., 2009; Wang et al., 2011). Reperfusion injury, a complex pathological process involving a variety of cytokines and signaling pathways, seriously affects the treatment and prognosis of patients with cerebral ischemia (Imai et al., 2007; Li et al., 2011). At present, there are no established methods and drugs for the treatment of cerebral I/R injury because there is a lack of clarity in the mechanism of function, safety, and ethics. Our data show that treatment with GPC could not only improve neurological function after focal cerebral ischemia caused by artery occlusion, but also significantly reduce infarct area and mortality rate, especially at a high dose. The underlying mechanism of its protective effects may be related to anti-oxygen radical and anti-inflammatory activity. The purpose of this study was to investigate the function of PCs, but only one dose of grape seed (40 mg/kg) was studied. Grape seed had a weaker influence on improving cerebral ischemia in rats compared with the same dose of GPC. We noted that GPC in each group could inhibit epilepsy caused by brain injury but GSPC did not. The anti-epilepsy mechanism of GPC needs further investigation.

Our data suggest that there was less nerve dysfunction in rats 8 hours after I/R operation in the GPCM, GPCH and nimodipine groups compared with the untreated I/R group. Nerve dysfunction in rats improved further 24 hours after operation, but was not obvious in the GSPC group. Our results show that compared with the I/R group, the infarct area was significantly reduced in the GPCM, GPCH and nimodipine groups, and suggested that GPC has protective effect against cerebral ischemia.

When acute cerebral infarction occurs, oxygen free radicals are produced through enzymatic and non-enzymatic systems; the latter can attack polyunsaturated fatty acids, which are abundant in vascular endothelial cells and brain cells (Weaver and Liu, 2015). Lipid peroxidation is initiated by free radicals and result in products such as aldehyde (MDA), keto, hydroxy, hydroperoxy carbonyl or inner peroxy radicals (Candelario-Jalil, 2009; Friedman, 2013; Zhang et al., 2014a). Free radical damage is one of the most important mechanisms of cerebral I/R injury and drugs that target free radicals are considered candidates to treat cerebral I/R injury (Viuda-Martos et al., 2014). MDA content is a measure of the degree of lipid peroxidation and indirectly indicates cell injury in the brain. Because of ischemia and free radical oxidation, SOD activity is decreased in the ischemic brain tissue. A large quantity of SOD is consumed during free radical scavenging and the enzyme activity decreases significantly. Therefore, SOD activity indirectly reflects the content of scavenged oxygen free radicals (Andersson et al., 2012; Rakhunde et al., 2014). Our results show that PC effect on cerebral ischemia may contribute to reducing excessive generation of free radicals and improving SOD activity in brain tissue, or act against oxygen free radical damage. GSPC has decreased MDA content, and increased SOD activity, but was not significantly different from the I/R group. The infarct area significantly reduced in the nimodipine group. However, there was no significant difference in MDA content and SOD activity between nimodipine and I/R groups, because the action of nimodipine to improve cerebral ischemia is not by antioxidant effect, but through a scavenged pathway of lipid peroxidation. Nimodipine is a kind of Ca2^+^ channel blocker, effectively prevents Ca2^+^ into the cells, inhibits the smooth muscle contraction, and relieves vasospasm (Yedinak,1993). We also measured the NO content in brain homogenates; the results demonstrated that GPC in each dose group significantly reduced the NO content in homogenates of ischemic brain tissue. Thus, the antioxidant activity in GPC plays an important role in the reduction of oxidative damage caused by excessive NO.

In conclusion, PC has preventive and protective effects on cerebral I/R injury in rats. The mechanism was associated with the decrease in oxidative injury. PC inhibits inflammatory reaction and activates survival pathways after I/R injury. Our study can provide evidence for relevant PC drugs.
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